4.7 Article

Effects of combination treatment with tezepelumab and allergen immunotherapy on nasal responses to allergen: A randomized controlled trial

Related references

Note: Only part of the references are listed.
Article Allergy

Baseline type 2 biomarker levels and response to tezepelumab in severe asthma

Jonathan Corren et al.

Summary: Tezepelumab significantly reduces T2 inflammatory biomarker levels and asthma exacerbation rates in patients with severe asthma. After 52 weeks of treatment, tezepelumab effectively reduces all measured biomarker levels and decreases asthma exacerbations.

ALLERGY (2022)

Article Medicine, General & Internal

Tezepelumab in Adults and Adolescents with Severe, Uncontrolled Asthma

Andrew Menzies-Gow et al.

Summary: Tezepelumab, a monoclonal antibody targeting thymic stromal lymphopoietin, effectively reduces asthma exacerbations in patients with severe, uncontrolled asthma, leading to improved lung function, asthma control, and quality of life.

NEW ENGLAND JOURNAL OF MEDICINE (2021)

Article Allergy

B lymphocytes directly contribute to tissue fibrosis in patients with IgG(4)-related disease

Emanuel Della-Torre et al.

JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY (2020)

Review Immunology

TSLP: from allergy to cancer

Jonathan Corren et al.

NATURE IMMUNOLOGY (2019)

Article Mathematical & Computational Biology

PanglaoDB: a web server for exploration of mouse and human single-cell RNA sequencing data

Oscar Franzen et al.

DATABASE-THE JOURNAL OF BIOLOGICAL DATABASES AND CURATION (2019)

Review Allergy

New approaches to allergen immunotherapy

Natasha C. Gunawardana et al.

ANNALS OF ALLERGY ASTHMA & IMMUNOLOGY (2018)

Review Immunology

Impact of allergen immunotherapy in allergic asthma

Wenming Zhang et al.

IMMUNOTHERAPY (2018)

Article Multidisciplinary Sciences

Thymic stromal lymphopoietin drives the development of IL-13(+) Th2 cells

Sotaro Ochiai et al.

PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2018)

Article Allergy

Mechanisms of allergen immunotherapy for inhaled allergens and predictive biomarkers

Mohamed H. Shamji et al.

JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY (2017)

Article Medicine, General & Internal

Tezepelumab in Adults with Uncontrolled Asthma

Jonathan Corren et al.

NEW ENGLAND JOURNAL OF MEDICINE (2017)

Article Allergy

Short-term subcutaneous grass pollen immunotherapy under the umbrella of anti-IL-4: A randomized controlled trial

Adam M. Chaker et al.

JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY (2016)

Article Biochemistry & Molecular Biology

Enrichr: a comprehensive gene set enrichment analysis web server 2016 update

Maxim V. Kuleshov et al.

NUCLEIC ACIDS RESEARCH (2016)

Article Medicine, General & Internal

Allergic Rhinitis

Lisa M. Wheatley et al.

NEW ENGLAND JOURNAL OF MEDICINE (2015)

Article Allergy

Expression of Mas-related gene X2 on mast cells is upregulated in the skin of patients with severe chronic urticaria

Daisuke Fujisawa et al.

JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY (2014)

Article Biochemical Research Methods

Enrichr: interactive and collaborative HTML5 gene list enrichment analysis tool

Edward Y. Chen et al.

BMC BIOINFORMATICS (2013)

Article Allergy

The placebo effect in allergen-specific immunotherapy trials

Annemie Narkus et al.

Clinical and Translational Allergy (2013)

Article Chemistry, Multidisciplinary

Mechanism of Immunoglobulin G4 Fab-arm Exchange

Theo Rispens et al.

JOURNAL OF THE AMERICAN CHEMICAL SOCIETY (2011)

Article Medicine, Research & Experimental

Eotaxin expression by epithelial cells and plasma cells in chronic asthma

RK Kumar et al.

LABORATORY INVESTIGATION (2002)